Obesity drug cocktail targets heart risks
NCT ID NCT01351753
First seen Mar 25, 2026 · Last updated May 13, 2026 · Updated 6 times
Summary
This study tested whether combining approved weight-loss drugs could help obese adults lose weight and improve blood vessel function. It involved 128 people aged 40-75 with obesity and at least one heart risk factor. The approach used drug combinations to target visceral fat and measure changes in weight and vascular health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52241, United States
Conditions
Explore the condition pages connected to this study.